Sanofi-Genzyme BioVentures

Sanofi-Genzyme BioVentures

Technical.ly Philly

Center City’s HealthVerity has acquired cloud-based drug rebate platform Curisium

$45,000,000 Venture capital (Series D)
Pulse 2.0

Evidation Health: $45 Million Funding And Sam Marwaha Joins As Chief Commercial Officer

FinSMEs

Evidation Health Raises $45M in Series D Funding

$46,000,000 Venture capital (Series A)
FinSMEs

Q32 Bio Raises $46M in Series A Funding

CNBC Tech

Omada Health scores $57 million as coronavirus pandemic sparks investor interest in health tech

$4,000,000 Seed fund
FinSMEs , Pulse 2.0

i2O Therapeutics Raises $4m in Seed Funding

the home of AI info

Unum Therapeutics Inc. (UMRX)'s Financial Results Comparing With Minerva Neurosciences Inc ...

Xconomy

With “Inflection Year” Ahead, Ovid Adds Novartis’s Tardio to C-Suite

Undisclosed
FinSMEs

Omada Health Receives Investment from Intermountain Ventures

MedCity News

Omada Health launches mental health programs using shuttered startup's tech

$30,000,000 Venture capital (Series C)
PE HUB

Evidation Health scores $30 mln Series C

Messaging
FinSMEs

Evidation Health Raises $30M in Series C Venture Capital Funding

Health Funding Cloud
MedCity News

Omada Health expands into chronic disease management for diabetes, hypertension

Health Apps & Services
socalTECH.com

Science37 Seeks $130M More For Clinical Trial Technology

Funding
Re/code

SoftBank is in talks to lead a $150 million investment in clinical trial startup Science 37

Robotics Funding Health
socalTECH.com

Science 37 Links With Pharmaceuticals Firm UCB

Funding Health
$69,200,000 IPO
PE HUB

VC-backed Unum Therapeutics rolls out IPO

Stock markets Health
Xconomy

Unum Therapeutics IPO Raises $69M to Test Universal Cell Therapies

Health Stock markets
$14,000,000 Venture capital (Series A)
FierceBiotech , businesswire , FinSMEs

Novartis, Sanofi-backed NeuroVia closes $14M series A for X-ALD work

Xconomy

NeuroVia Raises $14M to Test Drug for Rare, Fatal Metabolic Disease

Health Science